cilostazol has been researched along with thromboxane a2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K; Kobayashi, S; Nagakura, N; Saeki, T; Saito, I; Yamanaka, T; Yoshitake, S | 1 |
| Chida, M; Hoshikawa, Y; Kondo, T; Kubo, H; Song, C; Suzuki, S; Tabata, T | 1 |
| Grove, EL; Kristensen, SD | 1 |
1 review(s) available for cilostazol and thromboxane a2
| Article | Year |
|---|---|
Update on oral antiplatelet therapy: principles, problems and promises.
Topics: Adenosine; Administration, Oral; Cardiovascular Diseases; Cilostazol; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Tetrazoles; Thiophenes; Thromboxane A2; Ticagrelor | 2009 |
2 other study(ies) available for cilostazol and thromboxane a2
| Article | Year |
|---|---|
Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
Topics: Blood Platelets; Cilostazol; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Fatty Acids, Monounsaturated; Humans; In Vitro Techniques; Isoenzymes; Male; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Thromboxane A2 | 1996 |
Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats.
Topics: Animals; Aspirin; Blood Platelets; Cell Adhesion; Cilostazol; Endotoxins; Flow Cytometry; Hemodynamics; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles; Thromboxane A2 | 2004 |